STOCK TITAN

Planned sale of 3,448 AMLX (NASDAQ: AMLX) shares disclosed in Rule 144 filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

AMLX filed a notice under Rule 144 for a planned sale of restricted shares. The filing covers the proposed sale of 3,448 shares of common stock through Morgan Stanley Smith Barney LLC, with an aggregate market value of 50,515, on or about 02/02/2026 on NASDAQ. The issuer reports 144,693 shares of this class outstanding. The shares to be sold were acquired from the issuer on 02/02/2026 through the vesting of 9,167 restricted stock units, with no separate cash payment required.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the AMLX Rule 144 filing disclose about upcoming share sales?

The filing discloses a planned sale of 3,448 AMLX common shares under Rule 144. These shares, valued in total at 50,515, are expected to be sold on or about 02/02/2026 on NASDAQ through Morgan Stanley Smith Barney LLC.

How many AMLX shares are outstanding according to this Rule 144 notice?

The notice states that 144,693 shares of AMLX common stock are outstanding. This figure provides context for the planned sale of 3,448 shares and helps investors understand the relative size of the potential transaction in relation to the total share count.

How were the AMLX shares being sold under Rule 144 originally acquired?

The shares were acquired through the vesting of restricted stock units on 02/02/2026. The filing notes that 9,167 AMLX common shares were obtained from the issuer via this vesting event, with the nature of payment described as N/A rather than a separate cash purchase.

Which broker is handling the AMLX Rule 144 share sale and on which market?

The sale will be handled by Morgan Stanley Smith Barney LLC, located at 1 New York Plaza, 8th Floor, New York, NY 10004. The 3,448 AMLX common shares are expected to be sold on the NASDAQ market, as indicated in the filing.

What is the aggregate market value of AMLX shares to be sold under this notice?

The filing lists an aggregate market value of 50,515 for the 3,448 AMLX common shares to be sold. This figure reflects the total value of the planned transaction at the time of the notice, based on the market price used in the form.

Does the AMLX Rule 144 filer mention recent sales in the past three months?

The section requesting information on AMLX securities sold during the past three months is included but not populated with specific transactions. The form instead focuses on the newly acquired shares from restricted stock unit vesting and the planned 3,448-share sale described in the notice.
Amylyx Pharmaceuticals

NASDAQ:AMLX

AMLX Rankings

AMLX Latest News

AMLX Latest SEC Filings

AMLX Stock Data

1.61B
91.52M
9.5%
94.68%
9.43%
Biotechnology
Pharmaceutical Preparations
Link
United States
CAMBRIDGE